Published in BJU Int on November 01, 2010
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
Repeated variate stress in male rats induces increased voiding frequency, somatic sensitivity, and urinary bladder nerve growth factor expression. Am J Physiol Regul Integr Comp Physiol (2013) 0.94
Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil (2015) 0.87
Footshock stress differentially affects responses of two subpopulations of spinal dorsal horn neurons to urinary bladder distension in rats. Brain Res (2011) 0.84
Urinary bladder hypersensitivity and dysfunction in female mice following early life and adult stress. Brain Res (2016) 0.76
Angiogenic factors, bladder neuroplasticity and interstitial cystitis-new pathobiological insights. Transl Androl Urol (2015) 0.76
Genitourinary mast cells and survival. Transl Androl Urol (2015) 0.75
Infection and inflammation of the genitourinary tract. J Urol (2010) 0.75
Mast Cells, Mastocytosis, and Related Disorders. N Engl J Med (2015) 3.90
Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc (2002) 2.67
Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev (2007) 1.94
Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77
IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett (2003) 1.76
Neuroimmunology of stress: skin takes center stage. J Invest Dermatol (2006) 1.72
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology (2007) 1.67
Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol (2005) 1.58
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A (2010) 1.56
High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. Endocrinology (2003) 1.52
Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci (2004) 1.50
Impact of stress and mast cells on brain metastases. J Neuroimmunol (2008) 1.46
Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol (2005) 1.45
Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in Apolipoprotein E knockout mice. Cardiovasc Res (2002) 1.45
Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J Clin Psychopharmacol (2002) 1.45
Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol (2005) 1.44
Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol (2005) 1.31
Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther (2002) 1.23
Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology (2003) 1.14
Brain cytokines and neuropsychiatric disorders. J Clin Psychopharmacol (2004) 1.14
IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol (2003) 1.11
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci U S A (2006) 1.10
Serotonin-selective reuptake inhibitors and nonsteroidal anti-inflammatory drugs--important considerations of adverse interactions especially for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Psychopharmacol (2011) 1.09
Spectrum of mast cell activation disorders. Expert Rev Clin Immunol (2014) 1.08
Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci (2004) 1.07
Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. Atherosclerosis (2005) 1.05
Mitochondrial DNA and anti-mitochondrial antibodies in serum of autistic children. J Neuroinflammation (2010) 1.04
Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells. J Invest Dermatol (2011) 1.03
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitis. J Allergy Clin Immunol (2011) 1.02
Neurotensin is increased in serum of young children with autistic disorder. J Neuroinflammation (2010) 1.01
Role of mast cells in tumor growth. Ann Clin Lab Sci (2007) 1.01
Mast cells in allergic and inflammatory diseases. Curr Pharm Des (2012) 0.95
Autism: an emerging 'neuroimmune disorder' in search of therapy. Expert Opin Pharmacother (2009) 0.95
Effect of stress on brain inflammation and multiple sclerosis. Autoimmun Rev (2013) 0.95
Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation (2010) 0.94
Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol (2005) 0.94
Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr (2012) 0.94
Human mast cells stimulate activated T cells: implications for multiple sclerosis. Ann N Y Acad Sci (2008) 0.92
Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol (2007) 0.92
Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol (2006) 0.90
Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One (2012) 0.90
Use of polyphenols in periodontal inflammation. Eur J Pharmacol (2013) 0.89
Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch Allergy Immunol (2012) 0.88
Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One (2012) 0.88
Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. Neurochem Res (2012) 0.88
Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model. J Pharmacol Exp Ther (2008) 0.88
IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One (2012) 0.88
IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol (2010) 0.88
Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc (2002) 0.87
Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. Cardiovasc Res (2003) 0.87
Flavones inhibit proliferation and increase mediator content in human leukemic mast cells (HMC-1). Eur J Haematol (2003) 0.87
Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin. Am J Reprod Immunol (2004) 0.87
Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol (2010) 0.86
Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. J Immunol (2009) 0.86
Coronary stents, hypersensitivity reactions, and the Kounis syndrome. J Interv Cardiol (2007) 0.85
Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells. Int Arch Allergy Immunol (2003) 0.84
Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation. J Mol Endocrinol (2009) 0.84
Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye? J Autism Dev Disord (2011) 0.83
Systemic inflammation with multiorgan dysfunction is the cause of death in murine ligation-induced acute pancreatitis. J Gastrointest Surg (2011) 0.83
Interleukin-17 and the interleukin-17 family member network. Allergy Asthma Proc (2004) 0.83
Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol (2005) 0.82
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. Neurochem Int (2013) 0.82
Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. Adv Exp Med Biol (2007) 0.82
Neurotensin and CRH interactions augment human mast cell activation. PLoS One (2012) 0.82
Interleukin-6 and mast cells. Allergy Asthma Proc (2002) 0.82
Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists. Int Arch Allergy Immunol (2003) 0.82
Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice. Brain Res (2003) 0.82
Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells. Ann Allergy Asthma Immunol (2002) 0.81
Autism, gut-blood-brain barrier, and mast cells. J Clin Psychopharmacol (2008) 0.81
Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol (2007) 0.81
Interleukin-8 is increased in gingival crevicular fluid from patients with acute pulpitis. J Endod (2008) 0.81
Glia maturation factor expression in hippocampus of human Alzheimer's disease. Neurochem Res (2013) 0.81
Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes. J Mol Neurosci (2014) 0.81
Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol (2007) 0.81
Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis. Ann Allergy Asthma Immunol (2010) 0.81
Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain. Neurochem Res (2013) 0.80
Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells. Transl Res (2009) 0.80
Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells. J Mol Endocrinol (2005) 0.80
Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin. J Neuroinflammation (2012) 0.80
When to suspect interstitial cystitis. J Fam Pract (2011) 0.80